Home / Research and experimental development on chemicals (except medical and veterinary science)

COPLEY LABS PTE. LTD.

Live CompanyUEN 202441751HLocal Company

COPLEY LABS PTE. LTD. is a local company in Singapore with UEN 202441751H. It was registered on 10 Oct 2024, 1 years ago. Its status is Live Company. Its main activity is research and experimental development on chemicals (except medical and veterinary science).

UEN202441751H
StatusLive Company
Entity typeLocal Company, Exempt Private Company Limited by Shares
Registered10 Oct 2024
Main activity (SSIC)72103 Research and experimental development on chemicals (except medical and veterinary science)
Secondary activity46900 Wholesale trade of a variety of goods without a dominant product
Address10 ANSON ROAD, #23-05, INTERNATIONAL PLAZA, Singapore 079903
13438 companies at this address
AreaDowntown Core · District 2 (Anson, Tanjong Pagar)
Nearest stationTanjong Pagar MRT, about 69 m
Officers4
Last annual return3 Jul 2026

Newer companies in research and experimental development on chemicals (except medical and veterinary science)

  • ANVL PTE. LTD.202639992Z · 31 Aug 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • BAMCORE TECH PTE. LTD.202639601K · 28 Aug 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • PMA NANO CARBON TECHNOLOGY PTE. LTD.202616965H · 16 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • SILVERX TECHNOLOGY PTE. LTD.202616838H · 16 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • INNATUS THERAPEUTICS PTE. LTD.202616249E · 13 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • ABUNDANCE SPECIALTY CHEMICALS PTE. LTD.202611248M · 13 Mar 2026 · Research and experimental development on chemicals (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.